Axel Mark
3624
Renascience
4889
Ecomott
3987
Festaria Holdings
2736
Tecnisco
2962
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 8.38%243.57M | 137.81%224.73M | -32.19%94.5M | 572.62%139.35M | 20.72M |
Net profit before non-cash adjustment | 66.30%231.35M | 45.35%139.11M | -6.08%95.71M | 570.06%101.9M | --15.21M |
Total adjustment of non-cash items | -106.62%-3.46M | 1,455.48%52.21M | -113.92%-3.85M | 211.34%27.67M | --8.89M |
-Depreciation and amortization | -64.95%2.08M | -0.47%5.94M | -42.69%5.96M | 625.52%10.4M | --1.43M |
-Disposal profit | ---- | --12.44M | --0 | --0 | --1.16M |
-Other non-cash items | -116.36%-5.54M | 444.79%33.84M | -156.85%-9.82M | 174.40%17.27M | --6.29M |
Changes in working capital | -53.09%15.67M | 1,163.31%33.4M | -72.97%2.64M | 389.52%9.78M | ---3.38M |
-Change in receivables | 136.71%12.42M | -4.56%-33.83M | -24.38%-32.36M | 39.61%-26.01M | ---43.08M |
-Change in payables | -70.58%9.58M | 285.49%32.57M | -31.22%8.45M | -40.46%12.28M | --20.63M |
-Change in accrued expense | -113.36%-2.03M | 31.88%15.18M | 202.88%11.51M | -158.69%-11.19M | --19.07M |
-Provision for loans, leases and other losses | -150.04%-7.2M | -4.30%14.39M | -56.67%15.04M | --34.7M | --0 |
-Changes in other current assets | -43.04%2.9M | --5.09M | --0 | ---- | ---- |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -147.13%-818K | 32.72%-331K | 37.96%-492K | -46.58%-793K | -541K |
Interest received (cash flow from operating activities) | 1,214.29%92K | 40.00%7K | 25.00%5K | 100.00%4K | 2K |
Tax refund paid | -231.05%-56.87M | 78.61%-17.18M | -3,256.45%-80.3M | 114.36%2.54M | -17.72M |
Other operating cash inflow (outflow) | -1K | 0 | -1K | 0 | 0 |
Operating cash flow | -10.26%185.97M | 1,411.19%207.23M | -90.28%13.71M | 5,629.15%141.11M | --2.46M |
Investing cash flow | |||||
Net PPE purchase and sale | ---1.74M | --0 | ---17.7M | ---- | ---- |
Net investment product transactions | 0.00%-15M | -2,197.09%-15M | ---653K | ---- | ---- |
Net changes in other investments | -1,955.56%-1.11M | -100.51%-54K | 165.39%10.65M | ---16.28M | ---- |
Investing cash flow | -18.60%-17.85M | -95.35%-15.05M | 52.68%-7.71M | ---16.28M | --0 |
Financing cash flow | |||||
Net issuance payments of debt | 316.95%51.26M | 39.27%-23.63M | 0.00%-38.91M | -136.63%-38.91M | --106.23M |
Net common stock issuance | -98.60%2.22M | -6.83%158.39M | --170M | --0 | --89.5M |
Net other fund-raising expenses | 200,000.00%2M | 0.00%-1K | ---1K | ---- | --912K |
Financing cash flow | -58.83%55.48M | 2.80%134.76M | 436.95%131.09M | -119.79%-38.91M | --196.64M |
Net cash flow | |||||
Beginning cash position | 49.99%980.89M | 26.53%653.95M | 19.94%516.85M | 85.88%430.93M | --231.83M |
Current changes in cash | -31.61%223.6M | 138.47%326.94M | 59.57%137.1M | -56.85%85.92M | --199.1M |
Cash adjustments other than cash changes | ---- | ---- | --1K | ---- | ---- |
End cash Position | 22.80%1.2B | 49.99%980.89M | 26.53%653.95M | 19.94%516.85M | --430.93M |
Free cash flow | -11.10%184.23M | 5,296.31%207.23M | -102.83%-3.99M | 5,629.15%141.11M | --2.46M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |